Clinical Trial Update: RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update comparing raltegravir plus atazanavir/ritonavir versus regimens containing tenofovir/emtricitabine or lamivudine plus atazanavir/r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atazanavir/ritonavir (atazanavir/ritonavir)
• Lamivudine (lamivudine)
• Raltegravir (raltegravir)
• tenofovir disoproxil fumarate/emtricitabine (tenofovir disoproxil fumarate/emtricitabine)

Snippet

Sponsor: Pedro Cahn | Conditions: Chronic Infection With HIV | Phase 4 | Status: UNKNOWN